GB2353472A - Vaccine - Google Patents
VaccineInfo
- Publication number
- GB2353472A GB2353472A GB0027072A GB0027072A GB2353472A GB 2353472 A GB2353472 A GB 2353472A GB 0027072 A GB0027072 A GB 0027072A GB 0027072 A GB0027072 A GB 0027072A GB 2353472 A GB2353472 A GB 2353472A
- Authority
- GB
- United Kingdom
- Prior art keywords
- agent
- binding
- etxb
- ctxb
- vtxb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9809958.3A GB9809958D0 (en) | 1998-05-08 | 1998-05-08 | Vaccine |
GBGB9811954.8A GB9811954D0 (en) | 1998-05-08 | 1998-06-03 | Vaccine |
GBGB9812316.9A GB9812316D0 (en) | 1998-06-08 | 1998-06-08 | Cancer vaccines |
PCT/GB1999/001461 WO1999058145A2 (en) | 1998-05-08 | 1999-05-10 | Immunomodulators for vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0027072D0 GB0027072D0 (en) | 2000-12-20 |
GB2353472A true GB2353472A (en) | 2001-02-28 |
Family
ID=27269307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0027072A Withdrawn GB2353472A (en) | 1998-05-08 | 1999-05-10 | Vaccine |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1075274A2 (ja) |
JP (1) | JP4666761B2 (ja) |
KR (1) | KR20070067719A (ja) |
CN (1) | CN100335130C (ja) |
AU (1) | AU3939499A (ja) |
BR (1) | BR9910305A (ja) |
CA (1) | CA2331832A1 (ja) |
CZ (1) | CZ302333B6 (ja) |
EA (1) | EA004794B1 (ja) |
GB (1) | GB2353472A (ja) |
HU (1) | HUP0104842A3 (ja) |
IL (1) | IL139467A (ja) |
IS (1) | IS5694A (ja) |
MX (1) | MXPA00010934A (ja) |
NO (1) | NO20005599L (ja) |
NZ (1) | NZ507911A (ja) |
PL (1) | PL344519A1 (ja) |
WO (1) | WO1999058145A2 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9513371D0 (en) | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
GB9326174D0 (en) * | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
US20010036917A1 (en) | 1995-07-05 | 2001-11-01 | Williams Neil Andrew | Therapeutic agents |
GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
KR20010043441A (ko) | 1998-05-08 | 2001-05-25 | 더 유니버시티 오브 브리스톨 | 백신용 면역조절제 |
US7115730B1 (en) | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
GB0030067D0 (en) * | 2000-12-11 | 2001-01-24 | Univ Bristol | Therapeutic agent |
GB0115382D0 (en) | 2001-06-22 | 2001-08-15 | Univ Bristol | Mutant |
CN111100824B (zh) * | 2020-01-21 | 2021-11-05 | 暨南大学 | 一株芽孢杆菌及其在养殖水体中脱氮除硫的应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0372928A2 (en) * | 1988-12-07 | 1990-06-13 | University Of Leicester | Heat-labile toxin B subunit fusion proteins |
US5241053A (en) * | 1990-09-05 | 1993-08-31 | Takeda Chemical Industries, Ltd. | Fused proteins comprising glycoprotein gD of HSV-1 and LTB |
WO1997002045A1 (en) * | 1995-07-05 | 1997-01-23 | Oratol Limited | Therapeutic agents and autoimmune diseases |
EP0919243A1 (en) * | 1997-11-25 | 1999-06-02 | Duphar International Research B.V | Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant |
WO1999036088A1 (en) * | 1998-01-16 | 1999-07-22 | Maxim Pharmaceuticals, Inc. | RECOMBINANT CtB-BASED VACCINES |
-
1999
- 1999-05-10 AU AU39394/99A patent/AU3939499A/en not_active Abandoned
- 1999-05-10 KR KR1020077011045A patent/KR20070067719A/ko not_active Application Discontinuation
- 1999-05-10 CA CA 2331832 patent/CA2331832A1/en not_active Abandoned
- 1999-05-10 CZ CZ20004147A patent/CZ302333B6/cs not_active IP Right Cessation
- 1999-05-10 EP EP19990922284 patent/EP1075274A2/en not_active Withdrawn
- 1999-05-10 HU HU0104842A patent/HUP0104842A3/hu unknown
- 1999-05-10 BR BR9910305A patent/BR9910305A/pt not_active Application Discontinuation
- 1999-05-10 EA EA200001134A patent/EA004794B1/ru not_active IP Right Cessation
- 1999-05-10 GB GB0027072A patent/GB2353472A/en not_active Withdrawn
- 1999-05-10 PL PL34451999A patent/PL344519A1/xx unknown
- 1999-05-10 NZ NZ507911A patent/NZ507911A/en unknown
- 1999-05-10 WO PCT/GB1999/001461 patent/WO1999058145A2/en not_active Application Discontinuation
- 1999-05-10 CN CNB998084034A patent/CN100335130C/zh not_active Expired - Fee Related
- 1999-05-10 MX MXPA00010934A patent/MXPA00010934A/es not_active IP Right Cessation
- 1999-05-10 JP JP2000547996A patent/JP4666761B2/ja not_active Expired - Fee Related
-
2000
- 2000-10-31 IS IS5694A patent/IS5694A/is unknown
- 2000-11-05 IL IL139467A patent/IL139467A/en not_active IP Right Cessation
- 2000-11-06 NO NO20005599A patent/NO20005599L/no not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0372928A2 (en) * | 1988-12-07 | 1990-06-13 | University Of Leicester | Heat-labile toxin B subunit fusion proteins |
US5241053A (en) * | 1990-09-05 | 1993-08-31 | Takeda Chemical Industries, Ltd. | Fused proteins comprising glycoprotein gD of HSV-1 and LTB |
WO1997002045A1 (en) * | 1995-07-05 | 1997-01-23 | Oratol Limited | Therapeutic agents and autoimmune diseases |
EP0919243A1 (en) * | 1997-11-25 | 1999-06-02 | Duphar International Research B.V | Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant |
WO1999036088A1 (en) * | 1998-01-16 | 1999-07-22 | Maxim Pharmaceuticals, Inc. | RECOMBINANT CtB-BASED VACCINES |
Non-Patent Citations (6)
Title |
---|
Immunology (1997 Aug),91(4),p572-8; Nashar T O et al * |
Immunology today (1999 Feb), 20(2), p95-101; Williams N A et al * |
Infection and Immunty, US, American Society for Microbiology63(4), p1349-1355 * |
Journal of Infectious diseases (1998 Jun), 177(6), p1451-7 Richards C M et al * |
Medical Microbiology and Immunology (1998 Jun), 187(1), p3-10; Nashar T O et al * |
Society for applied bacteriology symposium series (1998), 27 26s-34s; Hirst T R et al * |
Also Published As
Publication number | Publication date |
---|---|
NO20005599D0 (no) | 2000-11-06 |
KR20070067719A (ko) | 2007-06-28 |
GB0027072D0 (en) | 2000-12-20 |
EA200001134A1 (ru) | 2001-08-27 |
WO1999058145A2 (en) | 1999-11-18 |
EP1075274A2 (en) | 2001-02-14 |
CA2331832A1 (en) | 1999-11-18 |
WO1999058145A3 (en) | 2000-02-03 |
CN1308546A (zh) | 2001-08-15 |
BR9910305A (pt) | 2001-01-09 |
CN100335130C (zh) | 2007-09-05 |
CZ20004147A3 (en) | 2001-05-16 |
IS5694A (is) | 2000-10-31 |
IL139467A (en) | 2011-11-30 |
JP2002514607A (ja) | 2002-05-21 |
HUP0104842A3 (en) | 2002-12-28 |
EA004794B1 (ru) | 2004-08-26 |
HUP0104842A2 (hu) | 2002-04-29 |
CZ302333B6 (cs) | 2011-03-16 |
NO20005599L (no) | 2001-01-08 |
IL139467A0 (en) | 2001-11-25 |
PL344519A1 (en) | 2001-11-05 |
NZ507911A (en) | 2004-04-30 |
AU3939499A (en) | 1999-11-29 |
JP4666761B2 (ja) | 2011-04-06 |
MXPA00010934A (es) | 2003-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG102259A (en) | Compostions with controlled paroxetine release | |
MXPA02012712A (es) | N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas. | |
UA34466C2 (uk) | Засіб для несистемної боротьби з паразитуючими комахами | |
AU5242000A (en) | Nematicidal trifluorobutenes | |
IL142768A0 (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
DE69528829D1 (de) | Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption | |
MX9601360A (es) | Mezcla estabilizante sinergistica. | |
MY132529A (en) | Paroxetine hydrochloride anhydrate | |
AU3126600A (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
GB2353472A (en) | Vaccine | |
ES2171969T3 (es) | Combinacion fusible de estabilizadores. | |
AR029590A1 (es) | Antibacterianos | |
WO2001087849A3 (en) | Modulators of tnf- alpha signaling | |
HUP0202592A2 (hu) | Lazofoxifen transzdermális adagolása | |
AU6724500A (en) | Motorcyclist suit | |
AU3284000A (en) | 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid- 4-yl)benzamide in the treatment of multiple sclerosis | |
EP1026162A4 (en) | ANTI-RHUMATISMAL AGENT | |
ES2157419T3 (es) | Arilazadioxacicloalquenos substituidos, fungicidas. | |
ID27733A (id) | Metoksiminofenilasetamida | |
ATE323493T1 (de) | Gesteuerte freisetzung von antidepressiva | |
EP1470101A4 (en) | NEW OPIOID DERIVATIVE | |
ATE491709T1 (de) | Pyrrolidinohydrochinazoline | |
AU2252997A (en) | Antifungal agent | |
DK0937094T3 (da) | Fremgangsmåde til fremstilling af ivermectin | |
DE69717147D1 (en) | Thrombin inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |